BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 25506042)

  • 1.
    Kunos CA; Debernardo R; Fabien J; Dobbins DC; Zhang Y; Brindle J; Faulhaber PF
    J Nucl Med Radiat Ther; 2011 Dec; Suppl 4(1):. PubMed ID: 25506042
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stereotactic radiosurgery for gynecologic cancer.
    Kunos C; Brindle JM; Debernardo R
    J Vis Exp; 2012 Apr; (62):. PubMed ID: 22546879
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prospective feasibility trial of radiotherapy target definition for head and neck cancer using 3-dimensional PET and CT imaging.
    Scarfone C; Lavely WC; Cmelak AJ; Delbeke D; Martin WH; Billheimer D; Hallahan DE
    J Nucl Med; 2004 Apr; 45(4):543-52. PubMed ID: 15073248
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dosimetric comparison of stereotactic body radiotherapy using 4D CT and multiphase CT images for treatment planning of lung cancer: evaluation of the impact on daily dose coverage.
    Wang L; Hayes S; Paskalev K; Jin L; Buyyounouski MK; Ma CC; Feigenberg S
    Radiother Oncol; 2009 Jun; 91(3):314-24. PubMed ID: 19111362
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The contribution of integrated PET/CT to the evolving definition of treatment volumes in radiation treatment planning in lung cancer.
    Ashamalla H; Rafla S; Parikh K; Mokhtar B; Goswami G; Kambam S; Abdel-Dayem H; Guirguis A; Ross P; Evola A
    Int J Radiat Oncol Biol Phys; 2005 Nov; 63(4):1016-23. PubMed ID: 15979817
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hematological toxicity after robotic stereotactic body radiosurgery for treatment of metastatic gynecologic malignancies.
    Kunos CA; Debernardo R; Radivoyevitch T; Fabien J; Dobbins DC; Zhang Y; Brindle J
    Int J Radiat Oncol Biol Phys; 2012 Sep; 84(1):e35-41. PubMed ID: 22543208
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Image-guided respiratory-gated lung stereotactic body radiotherapy: which target definition is optimal?
    Zhao B; Yang Y; Li T; Li X; Heron DE; Huq MS
    Med Phys; 2009 Jun; 36(6):2248-57. PubMed ID: 19610314
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of FDG-PET on radiation therapy volume delineation in non-small-cell lung cancer.
    Bradley J; Thorstad WL; Mutic S; Miller TR; Dehdashti F; Siegel BA; Bosch W; Bertrand RJ
    Int J Radiat Oncol Biol Phys; 2004 May; 59(1):78-86. PubMed ID: 15093902
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Automated functional image-guided radiation treatment planning for rectal cancer.
    Ciernik IF; Huser M; Burger C; Davis JB; Szekely G
    Int J Radiat Oncol Biol Phys; 2005 Jul; 62(3):893-900. PubMed ID: 15936575
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of five segmentation tools for 18F-fluoro-deoxy-glucose-positron emission tomography-based target volume definition in head and neck cancer.
    Schinagl DA; Vogel WV; Hoffmann AL; van Dalen JA; Oyen WJ; Kaanders JH
    Int J Radiat Oncol Biol Phys; 2007 Nov; 69(4):1282-9. PubMed ID: 17967318
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of different methods for delineation of 18F-FDG PET-positive tissue for target volume definition in radiotherapy of patients with non-Small cell lung cancer.
    Nestle U; Kremp S; Schaefer-Schuler A; Sebastian-Welsch C; Hellwig D; Rübe C; Kirsch CM
    J Nucl Med; 2005 Aug; 46(8):1342-8. PubMed ID: 16085592
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The impact of histology and delivered dose on local control of spinal metastases treated with stereotactic radiosurgery.
    Yamada Y; Katsoulakis E; Laufer I; Lovelock M; Barzilai O; McLaughlin LA; Zhang Z; Schmitt AM; Higginson DS; Lis E; Zelefsky MJ; Mechalakos J; Bilsky MH
    Neurosurg Focus; 2017 Jan; 42(1):E6. PubMed ID: 28041329
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The impact of (18)F-fluoro-2-deoxy-D-glucose positron emission tomography (FDG-PET) lymph node staging on the radiation treatment volumes in patients with non-small cell lung cancer.
    Vanuytsel LJ; Vansteenkiste JF; Stroobants SG; De Leyn PR; De Wever W; Verbeken EK; Gatti GG; Huyskens DP; Kutcher GJ
    Radiother Oncol; 2000 Jun; 55(3):317-24. PubMed ID: 10869746
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of FDG-PET on computed tomography-based radiotherapy planning for locally recurrent nasopharyngeal carcinoma.
    Zheng XK; Chen LH; Wang QS; Wu HB; Wang HM; Chen YQ; Yan WP; Li QS; Xu YK
    Int J Radiat Oncol Biol Phys; 2007 Dec; 69(5):1381-8. PubMed ID: 17869450
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumour delineation in oesophageal cancer - A prospective study of delineation in PET and CT with and without endoscopically placed clip markers.
    Thomas L; Lapa C; Bundschuh RA; Polat B; Sonke JJ; Guckenberger M
    Radiother Oncol; 2015 Aug; 116(2):269-75. PubMed ID: 26364886
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The impact of (18)FDG-PET on target and critical organs in CT-based treatment planning of patients with poorly defined non-small-cell lung carcinoma: a prospective study.
    Mah K; Caldwell CB; Ung YC; Danjoux CE; Balogh JM; Ganguli SN; Ehrlich LE; Tirona R
    Int J Radiat Oncol Biol Phys; 2002 Feb; 52(2):339-50. PubMed ID: 11872279
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Impact of computed tomography (CT) and 18F-deoxyglucose positron emission tomography (FDG-PET) image fusion for conformal radiotherapy in esophageal carcinoma].
    Moureau-Zabotto L; Touboul E; Lerouge D; Deniaud-Alexandre E; Grahek D; Foulquier JN; Petenief Y; Grès B; El Balaa H; Kerrou K; Montravers F; Keraudy K; Tiret E; Gendre JP; Grange JD; Hourry S; Talbot JN
    Cancer Radiother; 2005 May; 9(3):152-60. PubMed ID: 16023043
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Target delineation in stereotactic body radiation therapy for recurrent head and neck cancer: a retrospective analysis of the impact of margins and automated PET-CT segmentation.
    Wang K; Heron DE; Clump DA; Flickinger JC; Kubicek GJ; Rwigema JC; Ferris RL; Ohr JP; Quinn AE; Ozhasoglu C; Branstetter BF
    Radiother Oncol; 2013 Jan; 106(1):90-5. PubMed ID: 23333021
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison between 2-(18) F-fluoro-2-deoxy-d-glucose positron emission tomography and contrast-enhanced computed tomography for measuring gross tumor volume in cats with oral squamous cell carcinoma.
    Yoshikawa H; Randall EK; Kraft SL; Larue SM
    Vet Radiol Ultrasound; 2013; 54(3):307-13. PubMed ID: 23441633
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of FDG PET/CT on delineation of the gross tumor volume for radiation planning in non-small-cell lung cancer.
    Spratt DE; Diaz R; McElmurray J; Csiki I; Duggan D; Lu B; Delbeke D
    Clin Nucl Med; 2010 Apr; 35(4):237-43. PubMed ID: 20305410
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.